Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Application opens in 2017
There are three categories for submission:
Four abstracts will be selected for the ACCA Research Prize in Acute Cardiovascular Care 2018.
The winner (Best abstract) will get a prize of 3,000 EUR, including:
The next three selected will receive
Eligibility to apply is restricted to ACCA 2017 & 2018 members
Not yet a member?
All scientists/clinicians who submit their un-published research in the area of acute cardiovascular care with a focus on quality of care research, clinical outcomes research and translational research applied to the development of novel therapeutic, diagnostic and logistical strategies to improve patient care and long-term outcomes.
Submissions rules and call for abstracts
The four best scoring abstract submitters of the ACCA RESEARCH PRIZE FOR ACUTE CARDIOVASCULAR CARE will be notified by end 2017
Accepted abstracts are under embargo until one week before the Congress.
During embargo, accepted abstracts should not be published in any other journals and/or online publications or presented at any international congresses. Submitting or presenting published work may jeopardize future acceptance of abstracts.
The ACCA Research Prize initiative is supported by an unrestricted educational grants from AstraZeneca, , Novartis Pharma AG., The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company, The Medicines Company and ThermoFisher Scientific.
© 2017 European Society of Cardiology. All rights reserved